Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / CD Molecules

Recombinant Human CD158k/KIR3DL2 Protein, C-Fc

Catalog #:   EHE43801 Specific References (29) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: Mammalian Cells
Accession: P43630
Protein length: Met1-His338
Overview

Catalog No.

EHE43801

Expression system

Mammalian Cells

Species

Homo sapiens (Human)

Protein length

Met1-His338

Predicted molecular weight

63.37 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P43630

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution.A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

CD158K, MHC class I NK cell receptor, NKAT4, Natural killer-associated transcript 4, KIR3DL2, p70 NK receptor CL-5, CD158k, p70 natural killer cell receptor clone CL-5, CD158 antigen-like family member K, Killer cell immunoglobulin-like receptor 3DL2, NKAT-4

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Human CD158k / KIR3DL2
References

Evaluation of Sézary cell marker expression and cell death behaviour upon in vitro treatment by flow cytometry in Sézary syndrome patients., PMID:39219147

Histopathological Markers for Target Therapies in Primary Cutaneous Lymphomas., PMID:37998391

Clinical Guidelines and New Molecular Targets for Cutaneous Lymphomas., PMID:34681738

CD158k and PD-1 expressions define heterogeneous subtypes of Sezary syndrome., PMID:34570200

[Primary skin lymphomas: Current therapy]., PMID:30709635

Activating and inhibitory receptors on natural killer cells in patients with systemic lupus erythematosis-regulation with interleukin-15., PMID:29023581

Therapeutic Antibodies to KIR3DL2 and Other Target Antigens on Cutaneous T-Cell Lymphomas., PMID:28912774

KIR3DL2 (CD158k) is a potential therapeutic target in primary cutaneous anaplastic large-cell lymphoma., PMID:27037558

Sézary syndrome: old enigmas, new targets., PMID:26972187

Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma with KIR3DL2 and NKp46 expression in a human immunodeficiency virus carrier., PMID:25407699

CD158k is a reliable marker for diagnosis of Sézary syndrome and reveals an unprecedented heterogeneity of circulating malignant cells., PMID:25158034

Membrane expression of NK receptors CD160 and CD158k contributes to delineate a unique CD4+ T-lymphocyte subset in normal and mycosis fungoides skin., PMID:25044837

Skin-resident CD4+ T cells express NK receptors: lessons from skin pathologies., PMID:25044689

Use of PLS3, Twist, CD158k/KIR3DL2, and NKp46 gene expression combination for reliable Sézary syndrome diagnosis., PMID:23429988

New perspectives on the ligands and function of the killer cell immunoglobulin-like receptor KIR3DL2 in health and disease., PMID:23162554

CD158k/KIR3DL2 and NKp46 are frequently expressed in transformed mycosis fungoides., PMID:22621189

[New developments in Sézary syndrome]., PMID:22225740

Expression and function of the natural cytotoxicity receptor NKp46 on circulating malignant CD4+ T lymphocytes of Sézary syndrome patients., PMID:21191411

Absolute CD3+ CD158k+ lymphocyte count is reliable and more sensitive than cytomorphology to evaluate blood tumour burden in Sézary syndrome., PMID:19681856

NKG2D ligands expression and NKG2D-mediated NK activity in Sezary patients., PMID:18754036

CD158k/KIR3DL2 is a useful marker for identifying neoplastic T-cells in Sézary syndrome by flow cytometry., PMID:18061949

CD158K/KIR3DL2 transcript detection in lesional skin of patients with erythroderma is a tool for the diagnosis of Sézary syndrome., PMID:17703174

[Epidermotropic T cell lymphomas as models for tumor progression]., PMID:16457762

Significance of circulating T-cell clones in Sezary syndrome., PMID:16418328

T-cell large granular lymphocyte leukemias have multiple phenotypic abnormalities involving pan-T-cell antigens and receptors for MHC molecules., PMID:16416744

SC5 mAb represents a unique tool for the detection of extracellular vimentin as a specific marker of Sezary cells., PMID:16365461

CD158k/KIR3DL2 is a new phenotypic marker of Sezary cells: relevance for the diagnosis and follow-up of Sezary syndrome., PMID:15086570

Polymorphic expression of CD158k/p140/KIR3DL2 in Sézary patients., PMID:12529298

Engagement of ILT2/CD85j in Sézary syndrome cells inhibits their CD3/TCR signaling., PMID:12130517

Datasheet
$ 480
Product specifications
100 μg 480 1 mg 2880

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human CD158k/KIR3DL2 Protein, C-Fc [EHE43801]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only